NxThera Garners $18,200,000 Series C Funding Round

  • Feed Type
  • Date
    8/15/2013
  • Company Name
    NxThera
  • Mailing Address
    7351 Kirkwood Lane N Maple Grove, MN 55369
  • Company Description
    NxThera develops medical technologies to treat a variety of endourology conditions, including BPH. The company’s technology platform utilizes a simple, minimally invasive, vapor therapy designed to measurably improve urinary flow and patient quality of life.
  • Website
    http://www.nxthera.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $18,200,000
  • Transaction Round
    Series C
  • Proceeds Purposes
    NxThera will use this Series C capital to (i) conduct a U.S. clinical trial to seek FDA clearance to market its Rezum System to treat BPH, (ii) begin targeted, early commercialization of its Rezum System in selected European countries in 2014, and (iii) expand its applied research and feasibility studies to evaluate applications of its sterile water vapor technology to treat prostate cancer and kidney cancer.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.